Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Seagen Inc.    SGEN

SEAGEN INC.

(SGEN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SEATTLE GENETICS INC /WA : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)

10/08/2020 | 08:30am EST

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal

           Year.


Seattle Genetics, Inc. (the "Company") changed its corporate name to "Seagen Inc." by filing a Certificate of Amendment of the Fourth Amended and Restated Certificate of Incorporation of the Company (the "Certificate of Amendment") with the Secretary of State of the State of Delaware (the "Name Change") on October 6, 2020. The amendment was effected pursuant to Section 242 of the Delaware General Corporation Law, which permits such amendments to be adopted by a corporation's Board of Directors without stockholder approval. The Name Change was approved by the Company's Board of Directors on September 10, 2020.

The Name Change does not affect the rights of the Company's security holders. The Company's common stock will continue to trade on The Nasdaq Global Select Market under the symbol "SGEN" and the Company's new name of "Seagen Inc." will replace "Seattle Genetics, Inc." on The Nasdaq Global Select Market commencing on October 9, 2020.

The foregoing description of the Certificate of Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 and incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.




Exhibit
  No.                                    Description

3.1           Certificate of Amendment of the Fourth Amended and Restated
            Certificate of Incorporation of Seattle Genetics, Inc.

104         Cover Page Interactive Data File (formatted as Inline XBRL).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about SEAGEN INC.
11/16Didi Chuxing, BYD roll out customized vans for ride-hailing service
RE
11/09SEAGEN : Highlights Immuno-Oncology Data from Broad Portfolio During SITC Virtua..
BU
11/05SEAGEN : Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the..
BU
11/02SEAGEN : to Host Virtual R&D Day on November 16, 2020
BU
10/30SEAGEN : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/29SEATTLE GENETICS : 3Q Earnings Snapshot
AQ
10/29SEAGEN INC. : Results of Operations and Financial Condition (form 8-K)
AQ
10/29SEAGEN : Reports Third Quarter 2020 Financial Results
BU
10/29SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
AQ
10/28SEAGEN : Announces Closing of $1.0 Billion Stock Sale to Merck
BU
More news